Shorts should cover/buy before the next press release.
That's what I'm talking about.
Last day below $10.00.
The run-up is just beginning.
Even if it only goes to $25.00 this year that's still a nice return.
It's a virtual certainty.
Sanofi would be my choice for the European partner and also the eventual suitor longer term.
guess when ?
Sentiment: Strong Buy
Dendreon (DNDN) went to $55.00. :)
Arena is one of the most undervalued companies in the sector.